
Conference Coverage
about 5 hours ago
From Biologics to Bio-Machines: Top Takeaways From Maui Derm 2026Latest Content

PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency

Telomere Length and Polygenic Risk Shape Endotypes in Idiopathic Pulmonary Fibrosis

From Biologics to Bio-Machines: Top Takeaways From Maui Derm 2026

Is Rare Disease Policy a Stress Test of US Health Care?

Coalition's Conversation: The Employer Perspective

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

Aquestive Therapeutics receives a complete response letter for dibutepinephrine (Anaphylm), a sublingual epinephrine therapy.

Glaucoma is a leading cause of blindness in the US, making awareness of the condition vital to obtaining the best outcomes.

A European Respiratory Journal study shows pulmonary fibrosis affects sexual function and quality of life, calling for open clinician-patient conversations.

Prior authorization remains a major health care barrier, causing delays and frustrations for insured adults seeking necessary treatments.

Addressing poor medication adherence should be a top priority in health plans to ensure short- and long-term benefits in health outcomes and financial stability.

Patients on commercial insurance were more likely to have at least 1 chronic condition, which can affect health care spending overall.

Patients with mantle cell lymphoma experience improved quality of life and physical functioning after treatment with pirtobrutinib, a BTK inhibitor.

These findings suggest the mental health burden in nonmelanoma skin cancer reflects broader social and clinical factors rather than disease-specific effects.

Tildrakizumab at 100-mg and 200-mg doses showed long-term effectiveness for managing psoriasis in challenging areas in a real-world study.

Vutrisiran significantly reduces mortality and cardiovascular events in older patients with ATTR-CM, enhancing quality of life and functional capacity.





















